Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Lamb Weston übertrifft Prognosen, doch Aktie bricht ein (Investing.com DE) +++ LAMB WESTON Aktie -3,33%

Gewinn & Umsatz News zur AMICUS Aktie

 >AMICUS Aktienkurs 
12.1 EUR    +30.1%    (Tradegate)
Ask: 12.2 EUR / 1230 Stück
Bid: 12.1 EUR / 1250 Stück
Tagesumsatz: 7742 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
AMICUS Aktie über LYNX handeln
>AMICUS Performance
1 Woche: +11,2%
1 Monat: +13,3%
3 Monate: +30,6%
6 Monate: +86,1%
1 Jahr: +1,6%
laufendes Jahr: +1,6%
>AMICUS Aktie
Name:  AMICUS THERAPEUTICS INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US03152W1099 / A0MSMZ
Symbol/ Ticker:  AM6 (Frankfurt) / FOLD (NASDAQ)
Kürzel:  FRA:AM6, ETR:AM6, AM6:GR, NASDAQ:FOLD
Index:  -
Webseite:  https://amicusrx.com/
Profil:  Amicus Therapeutics Inc. is a biopharmaceutical co..
>Volltext..
Marktkapitalisierung:  2894.6 Mio. EUR
Unternehmenswert:  3047.32 Mio. EUR
Umsatz:  510.63 Mio. EUR
EBITDA:  35.92 Mio. EUR
Nettogewinn:  -11.99 Mio. EUR
Gewinn je Aktie:  -0.04 EUR
Schulden:  377.68 Mio. EUR
Liquide Mittel:  162.52 Mio. EUR
Operativer Cashflow:  11.07 Mio. EUR
Bargeldquote:  1.33
Umsatzwachstum:  15.07%
Gewinnwachstum:  87.26%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.411.687 USD.
Suchwörter:  AMICUS
Letzte Datenerhebung:  19.12.25
>AMICUS Kennzahlen
Aktien/ Unternehmen:
Aktien: 308.53 Mio. St.
Frei handelbar: 97.92%
Rückkaufquote: -0.07%
Mitarbeiter: 499
Umsatz/Mitarb.: 0.9 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 47.34%
Bewertung:
KGV: -
KGV lG: -
KUV: 5.08
KBV: 14.53
PEG-Ratio: -
EV/EBITDA: 84.83
Rentabilität:
Bruttomarge: 88.5%
Gewinnmarge: -2.35%
Operative Marge: 5.77%
Managementeffizenz:
Gesamtkaprendite: -1.7%
Eigenkaprendite: -6.87%
>AMICUS Peer Group

Es sind 599 Aktien bekannt.
 
11.04.25 - 20:45
Ex-OpenAI staffers file amicus brief opposing the company’s for-profit transition (TechCrunch)
 
A group of ex-OpenAI employees on Friday filed a proposed amicus brief in support of Elon Musk in his lawsuit against OpenAI, opposing OpenAI's planned conversion from a non-profit to a for-profit corporation. The brief names twelve former OpenAI employees: Steven Adler, Rosemary Campbell, Neil Chowdhury, Jacob Hilton, Daniel Kokotajlo, Gretchen Krueger, Todor Markov, Richard […]...
31.12.24 - 15:24
Encode Joins Musk In Fight Against OpenAI′s For-Profit Transition (ZeroHedge)
 
Encode Joins Musk In Fight Against OpenAI's For-Profit Transition Authored by Naveen Athrappully via The Epoch Times, Encode, an artificial intelligence (AI) advocacy group, filed a brief in support of Elon Musk's recent lawsuit against OpenAI, arguing that enabling the conversion toward a for-profit entity could endanger public interest. Musk filed a lawsuit against OpenAI last month, arguing that the entity was formed on promises that it would retain its nonprofit status focused on safe AI use. Musk said he invested in the project based on this premise. Disrupting the status quo “will seriously harm plaintiffs and the public at large,” the complaint said. In the brief, Encode is described as “a youth-led organization advocating for safe and responsible artificial intelligence (AI)” with “a network of over 1,000 volunteers across 40 countries.” On Dec. 27, Encode filed a proposed amicus curiae brief with the U.S. District Court for the Northern District of California, Oakland Di...
30.12.24 - 19:15
Nonprofit group joins Elon Musk’s effort to block OpenAI’s for-profit transition (TechCrunch)
 
Encode, the nonprofit organization that co-sponsored California's ill-fated SB 1047 AI safety legislation, has requested permission to file an amicus brief in support of Elon Musk's injunction to halt OpenAI's transition to a for-profit company. In a proposed brief submitted to the U.S. District Court for the Northern District of California Friday afternoon, counsel for […] © 2024 TechCrunch. All rights reserved. For personal use only....
27.12.24 - 22:42
Nonprofit group joins Elon Musk’s effort to block OpenAI’s for-profit transition (TechCrunch)
 
Encode, the nonprofit org that co-sponsored California's ill-fated SB 1047 AI safety legislation, has requested permission to file an amicus brief in support of Elon Musk's injunction to halt OpenAI's transition to a for-profit. In a proposed brief submitted to the U.S. District Court for the Northern District of California Friday afternoon, counsel for Encode […] © 2024 TechCrunch. All rights reserved. For personal use only....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Eine schüchterne Katze macht eine stolze Maus. - Sprichwort Großbritannien
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!